Back
Vertex Pharmaceuticals Stock Price Chart
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
49
VRTX
Vertex Pharmaceuticals
Last Price:
$407.63
Seasonality Move:
2.63%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing slight buying pressure.
Vertex Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 431.99 | Sell |
| 20-day SMA: | 452 | Sell |
| 50-day SMA: | 467.45 | Sell |
| 200-day SMA: | 457.15 | Sell |
| 8-day EMA: | 424.87 | Sell |
| 20-day EMA: | 444.59 | Sell |
| 50-day EMA: | 459.57 | Sell |
| 200-day EMA: | 452.41 | Sell |
Vertex Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -15.61 | Sell |
| Relative Strength Index (14 RSI): | 30.75 | Sell |
| Chaikin Money Flow: | 688227 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (428.98 - 475.2) | Sell |
| Bollinger Bands (100): | (451.5 - 489.4) | Sell |
Vertex Pharmaceuticals Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Vertex Pharmaceuticals Stock
Is Vertex Pharmaceuticals Stock a Buy?
-
Vertex Pharmaceuticals share price is 408.18 while VRTX 8-day simple moving average is 431.99, which is a Sell signal.
-
The stock price of VRTX is 408.18 while Vertex Pharmaceuticals 20-day SMA is 452.00, which makes it a Sell.
-
Vertex Pharmaceuticals 50-day simple moving average is 467.45 while VRTX share price is 408.18, making it a Sell technically.
-
VRTX stock price is 408.18 and Vertex Pharmaceuticals 200-day simple moving average is 457.15, creating a Sell signal.
VRTX Technical Analysis vs Fundamental Analysis
Sell
49
Vertex Pharmaceuticals (VRTX)
is a Sell
Is Vertex Pharmaceuticals a Buy or a Sell?
-
Vertex Pharmaceuticals stock is rated a SellThe current Vertex Pharmaceuticals [VRTX] share price is $408.18. The Score for VRTX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
Vertex Pharmaceuticals Stock Info
Market Cap:
105.1B
Price in USD:
408.18
Share Volume:
1.5M
Vertex Pharmaceuticals 52-Week Range
52-Week High:
519.88
52-Week Low:
377.85
Sell
49
Vertex Pharmaceuticals (VRTX)
is a Sell
Vertex Pharmaceuticals Share Price Forecast
-
What is the Vertex Pharmaceuticals stock price today?The Vertex Pharmaceuticals stock price is 408.18 USD today.
-
Will VRTX stock go up or go down?Vertex Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Vertex Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vertex Pharmaceuticals is overvalued.
Is Vertex Pharmaceuticals Stock a Buy?
-
Vertex Pharmaceuticals share price is 408.18 while VRTX 8-day exponential moving average is 424.87, which is a Sell signal.
-
The stock price of VRTX is 408.18 while Vertex Pharmaceuticals 20-day EMA is 444.59, which makes it a Sell.
-
Vertex Pharmaceuticals 50-day exponential moving average is 459.57 while VRTX share price is 408.18, making it a Sell technically.
-
VRTX stock price is 408.18 and Vertex Pharmaceuticals 200-day simple moving average is 452.41, creating a Sell signal.
Fundamental Analysis of Vertex Pharmaceuticals
Is Vertex Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.64 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.56 per share, and an increase next year of $18.20 per share.
Technical Analysis of Vertex Pharmaceuticals
Should I short Vertex Pharmaceuticals stock?
-
VRTX Moving Average Covergence Divergence (MACD) indicator is -15.61, suggesting Vertex Pharmaceuticals is a Sell
-
Vertex Pharmaceuticals Relative Strength Index (RSI) is 30.75, which suggest Vertex Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Vertex Pharmaceuticals is (428.98 - 475.2), which suggest Vertex Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Vertex Pharmaceuticals is (451.5 - 489.4), which suggest Vertex Pharmaceuticals is a Sell
* Vertex Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.